Predictors of poor outcome for transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC).
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.4100
Abstract: 4100 Background: The use of TACE in select patients with BCLC stage B HCC has been shown to improve survival. Despite this, it remains unclear which patients will benefit from repeated TACE versus switching to… read more here.
Keywords: bclc stage; hcc; tace; tace treatments ... See more keywords